Introduction: Split skin grafting is widely used surgical procedure for the treatment of ulcers. Graft survival depends on number of factors like vascularity, wound infection etc. diabetes is associated with endothelial dysfunction, neuropathy, wound infection which collectively affect the graft survival.
InTROduCTIOn
Split thickness skin graft (STSG) is a routinely used surgical procedure for treatment of ulcers which involves transfer of epidermis and part of the dermis from donor area to the recipient area. Split-thickness skin grafting is an age old plastic surgery procedure which is in use since 3000 BC in India for traumatic facial wounds. Though it was initially used for facial reconstruction, STSG is now commonly employed in reconstruction of burn wounds and to close chronic non-healing ulcers which are commonly seen in diabetic population. Survival of STSG depends on the vascularity of the recipient site. Presence of infection at the recipient site adversely affects the survival of graft.
Uptake of STSG takes place in three phases namely imbibition, revascularization and organization. Graft will securely adhere to the recipient bed by 10 to 14 days. Sensations return to the graft over time, pain is the first sensation to return within 4 to 5 weeks after grafting.
STSG in diabetic patients poses special concerns like the presence of neuropathy, endothelial dysfunction, and increased susceptibility to infection. Endothelial dysfunction leads to microvascular disruption that is preferably seen in kidneys, eyes and distal extremities. Neuropathy is another significant problem because the patients cannot appreciate pain and most of the times not aware of the severity of their wound until the infection extend more proximally. Diabetic patients are at an increased risk for wound infection. All these factors collectively influence the graft survival in diabetics.
This study is aimed to ascertain the survival of split-thickness skin graft in diabetic wounds and its reported risks and complications.
MATeRIAlS And MeThOdS
This is a prospective comparative study conducted in the constituent teaching hospitals of Kasturba Medical College Mangalore, Manipal University from December 2013 to July 2015. Institutional ethics committee permission was obtained. Total 104 patients were studied over a period of 1 year 8 months of which 52 were diabetics and 52 were nondiabetics. Subjects were selected by purposive sampling, a type of non-probability sampling method after applying inclusion and exclusion criteria.
Inclusion Criteria
All patients above the age of 18 years, undergoing SSG were included in the study. Wounds with healthy granulation tissue with no bacterial growth or scanty growth on culture were included in the study.
exclusion Criteria
Patients with age less than 18 years were excluded. Patients with peripheral arterial disease, HIV, malignancies, tuberculosis which hinders wound healing were excluded from the study. Wounds with moderate or heavy growth of organisms on culture were excluded.
Informed consent was obtained from all the subjects in the study. Patients who were diagnosed with diabetes and on medication and patients who were diagnosed recently with fasting sugar of >126 mg/dl or random blood sugar of >200 mg/dl were included in the diabetic group. All the patients underwent STSG for the management of ulcer after following standard criteria. All diabetic patients have their blood sugars under control before the procedure. Out of 52 patients in diabetic group 12 had hypertension, 7 had varicose veins. Out of 52 non-diabetic patients 8 had hypertension, 3 had varicose veins. All the patients with varicose veins were treated with surgery (Trendlenberg procedure with or without perforator ligation) before STSG. 6 of 52 patients in diabetic group were smokers, while 4 of 52 in non-diabetic group, were smokers.
Results were compared between two groups in terms of amount of graft uptake, post operative graft infection, need for revisional surgery, re-ulceration, donor site infection. Amount of graft uptake was calculated by measuring surface area of the wound that was grafted and area of the graft that was taken at fourteenth post-operative day. Surface area was measured with standard manual method of transparent sheet and graph paper [1] . All the patients in the study were followed for a period of 6 months.
ReSulTS
Total 104 patients were studied with 52 in each arm. Mean age of diabetic group was 51.8 years and that of non- Split skin grafting is commonly employed surgical method in the management of ulcers, which requires angiogenesis for its survival. As diabetic patients with microangiopathy have poor angiogenesis, they are at risk for graft failure. There are very few studies in the literature showing effect of diabetes on split skin graft survival.
Mowlavi et al., [15] reported decreased graft take in individuals with hyperglycemia; however, the authors used only preoperative serum glucose level, rather than duration of diabetes, in their analyses and did not distinguish between patients with and without the co-morbidities associated with diabetes.
Ramanujam et al., [16] retrospectively reviewed 203 patients who underwent STSG to ascertain the differences in healing time, necessity to perform revisional surgery and postoperative infections. With the help of this data, they developed a predictive model that can identify diabetic patients who are likely to have a successful STSG. Diabetic patients with preexisting co-morbidities were observed to have a higher risk of delayed healing, more susceptible to post-operative infections and prone to revisional surgery compared to nondiabetic patients or diabetic patients without co-morbidities. However, there were no significant differences in outcome between diabetic patients without co-morbidities and nondiabetic patients. Method of healing time measurement was not explained in this study. Only co-morbidities were considered in this study but not the duration of diabetes [17] [18] [19] .
In our study duration of diabetes and its impact on skin graft survival was considered and amount of graft survival was compared rather than duration of graft uptake. This study shows that post operative complications are significantly high in diabetics of longer duration. Rate of complete graft failure is significantly high in diabetic group.
In this study there is significant difference in mean age of diabetic and non-diabetic groups, furthermore, glycosylated hemoglobin levels, chronic kidney disease, blood urea levels, and serum creatinine concentration represent modifiable [Table/ Fig-10-12 ]: Show healthy wound over anterior aspect of left leg in a non-diabetic patient before and after grafting respectively. Shows good graft uptake in a diabetic patient with wound over right leg.
[ 
dISCuSSIOn
Diabetes mellitus is characterized by hyperglycemia that is caused due to improper secretion of insulin or defective action of insulin on cells or both. Diabetes is the most common metabolic disorder with a prevalence of around 62 million cases in India [2] .
Diabetes is associated with long term disease specific microangiopathy which leads to complications like nephropathy, neuropathy, and retinopathy. This microvascular dysfunction in diabetes will also affect adversely, the process of wound healing. Wound healing is impaired in diabetic patients and it is due to microvascular disease causing tissue hypoxia, peripheral neuropathy, and abnormal inflammatory and cellular pathways which predispose to infection in foot ulcers [3] [4] [5] [6] . Small fiber dysfunction is an early feature in patients with type 2 diabetes and it has been implicated in delayed wound healing [7, 8] . Wound healing is debilitated by several factors such as under-perfusion caused by reduced tissue response to the injury, dependent edema caused by a defective venoarteriolar reflex and an increase in capillary permeability [9, 10] . Many studies on humans showed no reduction in the density of skin capillaries. This result implies that microvascular function might be so abnormal that it reduces blood flow to the tissue even though there is no reduction in overall vascular density in patients suffering from diabetes [11, 12] . Recent studies on diabetic animals revealed a reduction in Vascular Endothelial Growth Factor (VEGF) which is known to promote angiogenesis and a tropical application of VEGF improved would healing [13, 14] .
